We are live on ! Find out more
NRC icon

NRC Health Common Stock

116 hedge funds and large institutions have $456M invested in NRC Health Common Stock in 2022 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 43 increasing their positions, 31 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

39% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 31

31% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 13

3% more funds holding

Funds holding: 113116 (+3)

0.82% more ownership

Funds ownership: 44.86%45.68% (+0.82%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

4% less capital invested

Capital invested by funds: $473M → $456M (-$17.1M)

Holders
116
Holders Change
+3
Holders Change %
+2.65%
% of All Funds
1.83%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
17
Increased
43
Reduced
31
Closed
13
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Kayne Anderson Rudnick Investment Management
1
Kayne Anderson Rudnick Investment Management
California
$131M -$590K -15,075 -0.5%
BlackRock
2
BlackRock
New York
$36.5M +$120K +3,053 +0.3%
Vanguard Group
3
Vanguard Group
Pennsylvania
$33.6M -$239K -6,103 -0.7%
ACM
4
Atlanta Capital Management
Georgia
$32.5M +$202K +5,171 +0.6%
CCA
5
Conestoga Capital Advisors
Pennsylvania
$28.9M +$17.2K +440 +0.1%
Dimensional Fund Advisors
6
Dimensional Fund Advisors
Texas
$24.9M -$111K -2,828 -0.4%
QI
7
QV Investors
Alberta, Canada
$18.4M +$18.1M +463,280 New
Renaissance Technologies
8
Renaissance Technologies
New York
$17.1M -$497K -12,700 -3%
State Street
9
State Street
Massachusetts
$12.3M +$714K +18,237 +6%
TC
10
Touchstone Capital
Pennsylvania
$11.1M +$173K +4,424 +2%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$10.5M +$457K +11,681 +5%
Northern Trust
12
Northern Trust
Illinois
$10M +$97.6K +2,492 +1%
NEI
13
Northwest & Ethical Investments
Ontario, Canada
$7.76M +$7.66M +195,690 New
Comerica Bank
14
Comerica Bank
Texas
$6.26M -$9.59K -245 -0.2%
Wells Fargo
15
Wells Fargo
California
$5M +$4.57M +116,757 +1,257%
Bank of America
16
Bank of America
North Carolina
$3.98M +$553K +14,131 +16%
Charles Schwab
17
Charles Schwab
California
$3.92M +$94.7K +2,419 +3%
Bank of New York Mellon
18
Bank of New York Mellon
New York
$3.58M +$69.5K +1,776 +2%
Royal Bank of Canada
19
Royal Bank of Canada
Ontario, Canada
$3.01M -$104K -2,666 -3%
Ohio Public Employees Retirement System (OPERS)
20
Ohio Public Employees Retirement System (OPERS)
Ohio
$2.96M
US Bancorp
21
US Bancorp
Minnesota
$2.95M +$261K +6,671 +10%
APC
22
Alpine Peaks Capital
New York
$2.84M -$298K -7,605 -10%
Daiwa Securities Group
23
Daiwa Securities Group
Japan
$2.73M
MAM
24
Montanaro Asset Management
United Kingdom
$2.66M
N
25
Nuveen
North Carolina
$2.29M +$67.6K +1,728 +3%

NRC Hedge Fund Activity: Q1 2022 in Review

116 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in NRC Health Common Stock (NRC) for Q1 2022, worth a combined $456M — down 3.6% from $473M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new NRC positions and 13 closed out — a net gain of 4 holders — while 43 added to existing stakes and 31 trimmed.

The largest buyer was QV Investors, opening a new position worth an estimated $18.1M. The largest seller was Neuberger Berman Group, cutting an estimated $19.8M.

  • 116 institutional investors held NRC Health Common Stock (NRC) as of Q1 2022, up from 113 in Q4 2021.
  • Funds reported $456M of NRC Health Common Stock stock for Q1 2022, down 3.6% quarter-over-quarter.
  • 17 funds opened new NRC Health Common Stock positions in Q1 2022 and 13 closed out, a net change of +4 holders.
  • The largest NRC Health Common Stock buyer in Q1 2022 was QV Investors, an estimated $18.1M added.
  • The largest NRC Health Common Stock seller in Q1 2022 was Neuberger Berman Group, an estimated $19.8M sold.

Based on aggregated 13F filings for Q1 2022.